Thanks for the story time Tada. I agree, exposure is critical at this point in the development of apabetalone and the history of the company. Also, it is not only about the presentations but also about the side talks and one on one meetings with current and potential investors, partners/collaborators and suitors. We are 25 months into BETonMACE, with the completion of enrollment and the sample size re-estimate analysis happening sometime before the end of next quarter. This developments this year will be the most exciting in the history of the company. So in my opinion, make the trips, make the presentations, have the meetings. Speak it loud, speak it proud, apabetalone is here to stay. The cost of these conferences pales in comparison to clinical trial costs, and the rewards can still be great.

BearDownAZ